Literature DB >> 10786673

Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction.

A C Hartford1, T Gohongi, D Fukumura, R K Jain.   

Abstract

Changes in distal angiogenesis in response to irradiation of primary tumors are not known. To this end, PC-3, a human prostate carcinoma, and FSA-II, a murine fibrosarcoma, were grown in the gastrocnemius muscles of male nude mice. Distal angiogenesis was measured in gel containing human recombinant basic fibroblast growth factor placed in the cranial windows of these mice. PC-3-bearing mice showed inhibition of distal angiogenesis, as compared with non-tumor-bearing controls. Surgical removal of tumors tended to accelerate distal angiogenesis; in comparison, after irradiation of the PC-3 primary tumor, rates of angiogenesis in the cranial window were retarded. Irradiation of the non-tumor-bearing leg or of non-tumor-bearing animals showed no measurable effect on rate of growth of vessels in the cranial window. Similar results were found with the FSA-II tumors, with slowed distal angiogenesis in tumor-bearing animals and further suppression in animals with irradiated tumors. These results demonstrate that the effect of irradiation of a primary tumor on angiogenesis at a distal site may differ from the effect of surgical removal of the primary tumor. Unlike surgery, irradiation of a tumor may enhance angiogenic suppression at a distal site, and this difference may involve host-tumor interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786673

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Recent advances in radiotherapy for soft-tissue sarcoma.

Authors:  Brian O'Sullivan; Iain Ward; Charles Catton
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

Review 2.  Local treatment of metastatic cancer--killing the seed or disturbing the soil?

Authors:  Scott C Morgan; Chris C Parker
Journal:  Nat Rev Clin Oncol       Date:  2011-06-07       Impact factor: 66.675

Review 3.  Anti-angiogenic therapy in pediatric neuro-oncology.

Authors:  Mark W Kieran
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

4.  Abscopal effect of boron neutron capture therapy (BNCT): proof of principle in an experimental model of colon cancer.

Authors:  Verónica A Trivillin; Emiliano C C Pozzi; Lucas L Colombo; Silvia I Thorp; Marcela A Garabalino; Andrea Monti Hughes; Sara J González; Rubén O Farías; Paula Curotto; Gustavo A Santa Cruz; Daniel G Carando; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2017-08-08       Impact factor: 1.925

5.  Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: a case report.

Authors:  Preethi Bangalore Lakshmanagowda; Lokesh Viswanath; Naveen Thimmaiah; Lokanath Dasappa; Sanjay Sudakar Supe; Pramod Kallur
Journal:  Cases J       Date:  2009-11-18

Review 6.  Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.

Authors:  Jose G Teodoro; Sara K Evans; Michael R Green
Journal:  J Mol Med (Berl)       Date:  2007-06-23       Impact factor: 4.599

Review 7.  Delivery of endostatin in experimental cancer therapy.

Authors:  Dag R Sorensen; Tracy-Ann Read
Journal:  Int J Exp Pathol       Date:  2002-12       Impact factor: 1.925

Review 8.  Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer.

Authors:  Paola Claudia Sacco; Paolo Maione; Antonio Rossi; Maria Anna Bareschino; Clorinda Schettino; Cesare Guida; Massimo Elmo; Rita Ambrosio; Valentina Barbato; Rosario Zeppa; Giovanni Palazzolo; Cesare Gridelli
Journal:  Target Oncol       Date:  2011-03-16       Impact factor: 4.864

9.  Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy.

Authors:  J J Jobsen; J van der Palen; M Baum; M Brinkhuis; H Struikmans
Journal:  Br J Cancer       Date:  2013-02-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.